Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:46 AM UTC
| NCT Number | NCT05573126 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 95 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Ellipses Pharma |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT05573126 is currently recruiting participants. This phase1 study for breast cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by Ellipses Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05573126 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05573126 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.